Arch Therapeutics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ARTH Over the counter 3841 https://www.archtherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arch Therapeutics Inc

Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”) - Apr 25th, 2023 10:50 am
Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect - Apr 5th, 2023 10:50 am
Arch Therapeutics’ AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code from The Centers for Medicare & Medicaid Services - Mar 9th, 2023 12:50 pm
Arch Therapeutics Announces Addition of Contract Sales Force to Advance Commercialization of AC5® Advanced Wound System in Government Facilities - Mar 7th, 2023 12:50 pm
Arch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound System - Jan 18th, 2023 12:35 pm
Arch Announces One-for-Two-Hundred Reverse Stock Split in Connection with Application for Uplisting to a National Exchange - Jan 17th, 2023 9:05 pm
The Centers for Medicare & Medicaid Services Makes Preliminary Recommendation to Establish New HCPCS Billing Code Dedicated to Arch Therapeutics’ AC5® Advanced Wound System - Dec 5th, 2022 11:50 am
Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Fall - Oct 18th, 2022 10:50 am
Arch Therapeutics’ AC5® Advanced Wound System to be Presented with Honors at 2022 Symposium on Advanced Wound Care (SAWC) Fall - Oct 11th, 2022 10:45 am
Arch Therapeutics Announces First Shipments of AC5® Advanced Wound System Under New Reimbursement Support Program - Sep 23rd, 2022 10:50 am
Arch Therapeutics Accepted to Present AC5® Advanced Wound System During Innovation Spotlight at 2022 Symposium on Advanced Wound Care (SAWC) - Sep 20th, 2022 10:50 am
Arch Therapeutics Announces Intent to Uplist from OTC to a National Exchange - Sep 16th, 2022 10:50 am
Arch Therapeutics Launches Multi-Site Clinical Study for AC5® Advanced Wound System - Sep 7th, 2022 10:50 am
Arch Therapeutics Submits Application to Centers for Medicare and Medicaid Services for AC5® Advanced Wound System - Sep 1st, 2022 10:50 am
Arch Therapeutics Raises Approximately $3.5 Million in Convertible Note Financing - Jul 7th, 2022 11:50 am
Arch Therapeutics Provides Update on Reimbursement Strategy in Additional Selling Channel - Jun 22nd, 2022 11:50 am